ci 719 d6

AH057 is a novel JAK inhibitor, effectively blocking the JAK STAT pathways by directly inhibiting JAK1 2 kinase activities, and leading to compromised cell proliferation and invasion, increasing apoptosis, arrested cell cycles, and impairing tumor progression in vitro and in vivo